Pharmacogenomics Variation in Drug Metabolizing Enzymes and Transporters in Relation to Docetaxel Toxicity in Lebanese Breast Cancer Patients: Paving the Way for OMICs in Low and Middle Income Countries-Reference-Cited by-同舟云学术

Pharmacogenomics Variation in Drug Metabolizing Enzymes and Transporters in Relation to Docetaxel Toxicity in Lebanese Breast Cancer Patients: Paving the Way for OMICs in Low and Middle Income Countries

Published:2013-07 Issue:7 Volume:17 Page:353-367
ISSN:1536-2310
Container-title:OMICS: A Journal of Integrative Biology
language:en
Short-container-title:OMICS: A Journal of Integrative Biology

Author:

Awada Zainab¹,Haider Syed²,Tfayli Arafat³,Bazarbachi Ali³,El-Saghir Nagi S.³,Salem Ziad³,Shamseddine Ali³,Taher Ali³,Zgheib Nathalie Khoueiry¹

Affiliation:

1. Department of Pharmacology and Toxicology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.

2. Centre for Molecular Oncology, Barts Cancer Institute—A Cancer Research UK Centre of Excellence Queen Mary, University of London John Vane Science Centre, London, United Kingdom.

3. Hematology-Oncology Division, Department of Internal Medicine, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine,Biochemistry,Biotechnology

Link

http://www.liebertpub.com/doi/pdf/10.1089/omi.2013.0019

Reference44 articles.

1. Pharmacogenetic Pathway Analysis of Docetaxel Elimination

2. Diagnosis of Dengue Virus Infection by Detection of Specific Immunoglobulin M (IgM) and IgA Antibodies in Serum and Saliva

3. Pharmacogenetic Screening of CYP3A and ABCB1 in Relation to Population Pharmacokinetics of Docetaxel

4. A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk

5. SNPnexus: a web database for functional annotation of newly discovered and public domain single nucleotide polymorphisms

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomics in Lebanon: current status, challenges and opportunities;The Pharmacogenomics Journal;2024-05-22

2. Discovery and identification of the prognostic significance and potential mechanism of FMO2 in breast cancer;Aging;2023-11-13

3. Cross‐Ancestry Genome‐Wide Association Study Defines the Extended CYP2D6 Locus as the Principal Genetic Determinant of Endoxifen Plasma Concentrations;Clinical Pharmacology & Therapeutics;2023-01-31

4. Association between Breast Cancer Polygenic Risk Score and Chemotherapy-Induced Febrile Neutropenia: Null Results;Cancers;2022-05-31

5. Impact of variants in ATP-binding cassette transporters on breast cancer treatment;Pharmacogenomics;2020-12